1st Edition

The Commercial Use of Biodiversity Access to Genetic Resources and Benefit-Sharing

By Kerry Ten Kate, Sarah A Laird Copyright 1999
418 Pages
by Routledge

418 Pages
by Routledge

418 Pages
by Routledge

Originally published in 1999 The Commercial Use of Biodiversity examines how biodiversity and the genetic material it contains are now as valuable resources. Access to genetic resources and their commercial development involve a wide range of parties such as conservation and research institutes, local communities, government agencies and companies. Equitable partnerships are not only crucial to... Read more

List of Boxes, Figures and Tables

Acronyms and Abbreviations

Foreword

Acknowledgments

1 Introduction

2. Regulation Access to Genetic Resources and Benefit-Sharing: The Legal Aspects

3. Natural Products and the Pharmaceutical Industry

4. The Botanical Medicine Industry

5. The Development of Major Crops by the Seed Industry

6. Horticulture

7. Crop Protection

8. Biotechnology in Fields Other Than the Healthcare and Agriculture

9. The Natural Personal Care and Cosmetics Industry

10. Industry and the CBD

11. Conclusions

12. Recommendations

Appendix A: The Influence of Natural Products on 1997 Pharmaceutical Sales Figures

Appendix B: Scientific and Common Names of Selected Botanical Medicines

Appendix C: Regulatory Frameworks for Botanical Medicines

Appendix D: Tentative List of Crops Under Negotiation as the Scope of the Multilateral System in the Revised International Undertaking

Appendix E: Regulatory Frameworks Relevant to the Release of Crop Varieties

Useful Contacts and Sources of Information

Glossary

Bibliography

Research Methodology and Team

Index

Biography

Kerry Ten Kate, Sarah A Laird